Circulating exosomal micro RNAs in acquired aplastic anemia Slides: 6 Download presentation Circulating exosomal micro. RNAs in acquired aplastic anemia and myelodysplastic syndromes by Valentina Giudice, Lauren G. Banaszak, Fernanda Gutierrez-Rodrigues, Sachiko Kajigaya, Reema Panjwani, Maria del Pilar Fernandez Ibanez, Olga Rios, Christopher K. Bleck, Erin S. Stempinski, Diego Quinones Raffo, Danielle M. Townsley, and Neal S. Young haematol Volume 103(7): 1150 -1159 July 3, 2018 © 2018 by Ferrata Storti Foundation mi. RNAs in severe aplastic anemia (SAA) and myelodysplastic syndromes (MDS) patients compared to healthy controls (HC) in the discovery set. Valentina Giudice et al. Haematologica 2018; 103: 1150 -1159 © 2018 by Ferrata Storti Foundation Validation of mi. RNA signatures in severe aplastic anemia (SAA) and myelodysplastic syndromes (MDS) patients. Valentina Giudice et al. Haematologica 2018; 103: 1150 -1159 © 2018 by Ferrata Storti Foundation Exosomal mi. RNAs in severe aplastic anemia (SAA) and myelodysplastic syndromes (MDS) patients. Valentina Giudice et al. Haematologica 2018; 103: 1150 -1159 © 2018 by Ferrata Storti Foundation Exosomal mi. RNAs and their correlation with prognosis in severe aplastic anemia (SAA) responders. Valentina Giudice et al. Haematologica 2018; 103: 1150 -1159 © 2018 by Ferrata Storti Foundation Pathway analysis using differentially expressed exosomal mi. RNAs. Valentina Giudice et al. Haematologica 2018; 103: 1150 -1159 © 2018 by Ferrata Storti Foundation